![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t2.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/01/table1.png)
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK
![Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2422995/bin/cuaj1377T2.jpg)
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value | PLOS ONE
Detection of prostate specific antigen (PSA) in human saliva using an ultra-sensitive nanocomposite of graphene nanoplatelets with diblock-co-polymers and Au electrodes - Analyst (RSC Publishing)
![Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience | Radiation Oncology | Full Text Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-021-01808-3/MediaObjects/13014_2021_1808_Fig2_HTML.png)